# US 2008/0305189 A1 · Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305189 A1
- Document ID: US20080305189A1
- Status: Published application
- Kind: A1
- Application number: 12/194,879
- Filed: 2008-08-20
- Published: 2008-12-11
- Earliest claimed: 2003-08-28
- Assignees: Tianjin Tasly Pharmaceutical Co., Ltd.
- Inventors: Xijun YAN; Naifeng WU; Zhengliang YE; Xu LI; Zhixin GUO; Na ZHAO
- Web page: https://patentgrep.com/patent/US20080305189A1

## CPC

- A61K 36/537: Salvia (sage)
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/258: Panax (ginseng)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to the treatment of aspirin resistant cardio-cerebrovascular diseases using RSM (RSM), its extract and composition comprising any or both of them, especially the formulation Dan Shen Drop Pills (Drop Pills of RSM).

## Claims

### Claim 1

A method for treating anti-aspirin resistance in a subject, comprising administering at least one of RSM, RSM extract and a composition including at least one of RSM and RSM extract as an active ingredient to said subject in need of such treatment.

### Claim 2 (depends on 1)

The method of claim 1 wherein said aspirin resistance is an aspirin resistant cardio-cerebrovascular disease.

### Claim 3 (depends on 2)

The method of claim 2 wherein said aspirin resistant cardio-cerebrovascular disease includes at least one of coronary heart disease and angina pectoris.

### Claim 4 (depends on 1)

The method of claim 1 wherein said composition includes a compound preparation including at least one of RSM and RSM extract.

### Claim 5 (depends on 4)

The method of claim 4 wherein said compound preparation is selected from the group consisting of danhong injection, qianglinaoxinkang, tongxinshu capsules, compound dangshen tablets, danxiang guanxin injection, danshen injection, jingzhi guanxin granules, jingzhi guanxin tablets, shuxintong capsules, xinnaoning capsules, guanxindanshao tablets, xinxinshu capsules, xiongxiangtongmai pills, guanxindanshen tablets, guanxindanshen drop pills, compound danshen drop pills, and compound danshen tablets.

### Claim 6 (depends on 4)

The method of claim 4 wherein said composition comprises RSM 30-180 parts, Radix Notoginseng 5-40 parts, Borneolum 0.3-2.5 parts, and adjuvants 10-40 parts.

### Claim 7 (depends on 6)

The method of claim 6 wherein said composition comprises RSM 75-115 parts, Radix Notoginseng 14-20 parts, Borneolum 0.8-1.2 parts, and adjuvants 15-30 parts.

### Claim 8 (depends on 7)

The method of claim 7 wherein said composition comprises RSM 90 parts, Radix Notoginseng 17.6 parts, Borneolum 1 part, and adjuvants 20 parts.

### Claim 9 (depends on 6)

The method of claim 6 wherein said adjuvants include polyethylene glycol.

### Claim 10 (depends on 4)

The method of claim 4 wherein said composition is selected from the group consisting of drop pills, spray solution, pellets, pills, granules, capsules, tablets, powder and oral liquid.
